Canada Pension Plan Investment Board
CSTL icon

Canada Pension Plan Investment Board’s Castle Biosciences CSTL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Buy
11,400
+5,100
+81% +$167K ﹤0.01% 1442
2025
Q4 		$245K Buy
6,300
+3,900
+163% +$126K ﹤0.01% 1584
2025
Q3 		$54.6K Buy
+2,400
New +$48.8K ﹤0.01% 1244
2025
Q2 		– Sell
-2,400
Closed -$48K – 1374
2025
Q1 		$48K Buy
2,400
+1,500
+167% +$37.1K ﹤0.01% 1206
2024
Q4 		$24K Buy
+900
New +$27.4K ﹤0.01% 1355

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board's CSTL Position: Q1 2026 in Review

Canada Pension Plan Investment Board increased its Castle Biosciences (CSTL) stake by 81% in Q1 2026, buying an estimated $167K and bringing the position to 11,400 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Canada Pension Plan Investment Board first reported a position in CSTL in Q4 2024 and has held it in 5 quarters since. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Canada Pension Plan Investment Board held 11,400 shares of Castle Biosciences worth $280K as of Q1 2026.
  • Canada Pension Plan Investment Board bought 5,100 Castle Biosciences shares in Q1 2026, an estimated $167K.
  • Castle Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1442 holding.
  • Canada Pension Plan Investment Board first reported a position in Castle Biosciences in Q4 2024 and has held it in 5 quarters since.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.